在血液癌症中弥合骨髓移植和CAR-T细胞治疗之间的差距

Babak Arjmand1, Fatemeh Shahrahmani2, Alieh Mirzaei3

  • 1Hematology-Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. barjmand@sina.tums.ac.ir.

概括

骨髓移植和CAR T细胞疗法是血液癌症的关键. 整合这些治疗方法,同时管理CRS和GVHD等副作用,提供个性化和可持续的癌症护理.